The jist of it is that BIEL has a lot of products that treat back pain, knee pain, heel pain etc. The have an approval for eye patch status post surgical procedure for blepharoplasty (eye lid treatment) that has to be written by Rx or used in a surgery center. It is used in a small niche market. They have applied and been painfully waiting for approval of their patches to be sold over the counter. Seems pretty simple but is very complex because they are starting a new category of treatment. The FDA is and has been asking for more information on several occasions. BIEL and management submit stuff and say they expect an answer then the FDA comes back with more questions. In the meantime the stock price falls while the wait continues. There is also some speculation of dilution that BIEL may or may not have done to keep money flowing. They have gotten approval in other countries but sales are lagging. Most of us longs feel the U.S. is the big ticket and should propel our stock to at least 10 cents. That is a very low estimate but very realistic. I am actually hoping eventually for a $1 but don't know if that will happen. We will just have to wait and see. All just my take on things and my opinion. By the way this is the cliff notes version. If you got in last week then I think you caught the ride up as there will be a conference call on Oct. 6th and this is speculation buying.
News 
Market Data 
Discover 
AI
